Overview
Location
Sweden, Stockholm
Employees
11-50
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 22, 2025 | Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m - HealthCap and Hadean Growth Fund Join Strong Investor Syndicate | Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m - HealthCap and Hadean Growth Fund Join Strong Investor Syndicate Tue, Jul 22, 2025 10:00 CET Report this content STOCKHOLM, SWEDEN - July 22, 2025. Gesynta Pharma AB... |
| May 14, 2025 | Interim report January – March 2025 | Interim report January – March 2025 Wed, May 14, 2025 08:30 CET Report this content The Group in summary 01/01/25 01/01/24 01/01/24 -31/03/25 -31/03/24 -31/12/24 Net sales 4 574 2 394 11 787 Operating result -13 537 -17 979 -77 277 Result a... |
| Apr 24, 2025 | Healthcap picks up €48m from LP pair towards latest life sciences VC fund | A pair of Danish institutional investors have committed €48m towards the latest venture capital fund being raised by S |
| Mar 1, 2025 | The Housing Market's Pulse: Besqab's Strategic Move in Solna | In the bustling landscape of real estate, timing is everything. Besqab AB, a prominent player in the Swedish housing market, has made a significant move by acquiring 130 residential building rights in Solna. This acquisition is not just a t... |
| Feb 24, 2025 | Intervacc announces the outcome of the rights issue | Intervacc announces the outcome of the rights issue Mon, Feb 24, 2025 19:55 CET Report this content NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, B... |
| Dec 21, 2024 | Intervacc AB: A Strategic Leap Forward with Upcoming Rights Issue | Intervacc AB, a Swedish biotech company, is gearing up for a significant financial maneuver. On December 19, 2024, the Board of Directors announced a rights issue aimed at raising approximately SEK 225 million. This decision, pending approv... |
| Dec 19, 2024 | The Board of Directors of Intervacc resolves on a rights issue of approximately SEK 225 million | The Board of Directors of Intervacc resolves on a rights issue of approximately SEK 225 million Thu, Dec 19, 2024 08:00 CET Report this content NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR... |
| Jul 23, 2015 | Daily funding roundup - July 23, 2015 | Flipboard raised $50M; Notion Capital launched $120M; CarPrice closed $40M CarPrice wants to be the company that brings the process of buying used cars in Russia online closed $40 million in Series B funding. The round was led by Baring Vos... |
| Sep 29, 2014 | Pulmologix Raises €9.6M | Pulmologix, a Stockholm, Sweden-based developer of a new oral non-steroidal anti-asthmatic drug, raised €9.6M in Series B funding. The round was led by Novo Seeds and Sunstone Capital with participation from previous investors Forbion Capit... |
Show more
Reviews 0
FAQ about HealthCap
What has the press written about HealthCap?
Parsers VC has collected 15 articles mentioning HealthCap, among them “Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m - HealthCap and Hadean Growth Fund Join Strong Investor Syndicate” (Jul 22, 2025) and “Interim report January – March 2025” (May 14, 2025).
Is HealthCap still active?
HealthCap is probably closed: its latest activity on Parsers VC dates from Oct 20, 2026.